Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:1.13.12.5 (aequorin)
 1,451 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The photoprotein aequorin generates blue light upon binding of Ca(2+) ions. Together with its very low Ca(2+)-buffering capacity and the possibility to add specific targeting sequences, this property has rendered aequorin particularly suitable to monitor Ca(2+) concentrations in specific subcellular compartments. Recently, a new generation of genetically encoded Ca(2+) probes has been developed by fusing Ca(2+)-responsive elements with the green fluorescent protein (GFP). Aequorin has also been employed to this aim, resulting in an aequorin-GFP chimera with the Ca(2+) sensitivity of aequorin and the fluorescent properties of GFP. This setup has actually solved the major limitation of aequorin, for example, its poor ability to emit light, which rendered it inappropriate for the monitoring of Ca(2+) waves at the single-cell level by imaging. In spite of the numerous genetically encoded Ca(2+) indicators that are currently available, aequorin-based probes remain the method of election when an accurate quantification of Ca(2+) levels is required. Here, we describe currently available aequorin variants and their use for monitoring Ca(2+) waves in specific subcellular compartments. Among various applications, this method is relevant for the study of the alterations of Ca(2+) homeostasis that accompany oncogenesis, tumor progression, and response to therapy.
...
PMID:Methods to measure intracellular Ca(2+) fluxes with organelle-targeted aequorin-based probes. 2492 26